GGrantIndex
← Leaderboards

Biological Mimetics, Inc.

Frederick, MD

Compare ↔
$14,638,230
Total funding
18
Grants

Funding over time

peak $2.1M · FY2005–25
$2.5M$1.9M$1.3M$625K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$14,638,230 · 18

By mechanism

R44$7,273,546 · 2
R43$4,765,218 · 12
N43$1,798,461 · 2
R21$801,005 · 2

Investigators at Biological Mimetics, Inc.

Investigator-initiatedAll funding

InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).

Rising Stars

First grant in the last 5 yrs

Not enough data

Emerging Leaders

6–10 yrs in

1Stephen Jeffrey Dollery$1,106,2013 gr2David A Macleod$598,4361 gr

All-Time

Most funded here, all years

1Gregory John Tobin$9,434,1288 gr2Stephen Jeffrey Dollery$1,106,2013 gr3David A Macleod$598,4361 gr4George Lin$569,2321 gr5Robert R Garrity$231,7731 gr

Largest grants

FAST – CRISPR-based Diagnostic for Parasites$1,498,641
N43 · FY2025 · AI
Development of the first HRV vaccine$999,998
R44 · FY2016 · AI
Development of the first HRV vaccine$999,998
R44 · FY2015 · AI
Nonclinical Development of an Improved Polio Vaccine$990,662
R44 · FY2022 · AI
Nonclinical Development of an Improved Polio Vaccine$976,542
R44 · FY2023 · AI
Development of the first HRV vaccine$923,094
R44 · FY2014 · AI
Nonclinical Development of an Improved Polio Vaccine$917,012
R44 · FY2024 · AI
Development of an improved, low-cost polio vaccine (Ir-IPV)$743,104
R44 · FY2017 · AI
Development of an improved, low-cost polio vaccine (Ir-IPV)$723,136
R44 · FY2018 · AI
Immune Dampening the OMPs of non-typeable H. influenzae$300,000
R43 · FY2003 · AI
Masking the GH-loop: model for human Rhinovirus vaccine$300,000
R43 · FY2001 · AI
Immune Dampening the OMPs of non-typeable H. influenzae$299,999
R43 · FY2004 · AI
CRISPR-based Diagnostic for Parasites$299,820
N43 · FY2023 · AI
Manganese-peptide Countermeasures for Radiation Exposure$299,372
R43 · FY2018 · AI
Development of a Universal Influenza Vaccine$299,218
R43 · FY2021 · AI
Development of a Universal Influenza Vaccine$299,218
R43 · FY2020 · AI
Development of a novel human rhinovirus vaccine$299,164
R43 · FY2011 · AI
Development of a novel human rhinovirus vaccine$298,345
R43 · FY2010 · AI
An instrument-free malaria diagnostic$297,761
R43 · FY2024 · AI
Development of a Staph Aureus Vaccine$296,442
R43 · FY2024 · AI